talazoparib
Showing 1 - 25 of 59
Metastatic Castration-Resistant Prostate Cancer Trial (Talazoparib)
Available
- Metastatic Castration-Resistant Prostate Cancer
- Talazoparib
- (no location specified)
Dec 6, 2022
Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial (Pidnarulex, Talazoparib)
Not yet recruiting
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Pidnarulex
- Talazoparib
- (no location specified)
Jun 15, 2022
Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)
Recruiting
- Metastatic Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- Talazoparib
- Tazemetostat
-
Boston, Massachusetts
- +1 more
Jul 18, 2022
Acute Myeloid Leukemia Trial in Stanford (Talazoparib, Topotecan, Gemcitabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Talazoparib
- +2 more
-
Stanford, CaliforniaStanford University
Jun 10, 2022
Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)
Active, not recruiting
- Acute Myeloid Leukemia
- Decitabine
- talazoparib
-
Baltimore, MarylandUniversity of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Pittsburgh (ZEN003694, Talazoparib)
Recruiting
- Ovarian Cancer
- +2 more
- ZEN003694
- Talazoparib
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Apr 27, 2022
Metastatic or Unresectable Melanoma Trial in Cleveland (Nivolumab, Talazoparib)
Recruiting
- Metastatic or Unresectable Melanoma
- Nivolumab
- Talazoparib
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Mar 22, 2022
Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +5 more
- BET Bromodomain Inhibitor ZEN-3694
- Talazoparib
- (no location specified)
Aug 3, 2022
Tumors Trial in Changchun, Beijing (talazoparib)
Completed
- Neoplasms
- talazoparib
-
Changchun, Jilin, China
- +1 more
Jan 12, 2022
Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Ovarian Carcinoma Trial in Ann Arbor
Recruiting
- Metastatic Breast Cancer
- +2 more
- Talazoparib
- Belinostat
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Mar 31, 2022
US Talazoparib-Treated Locally Advanced or Metastatic Breast
Completed
- Breast Cancer
- Talazoparib
-
New York, New YorkPfizer Inc
Nov 22, 2021
HRD 100 Gene Expression High, Triple Negative Breast Cancer Trial in Kuala Lumpur (Talazoparib)
Recruiting
- HRD 100 Gene Expression High
- Triple Negative Breast Cancer
- Talazoparib
-
Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, MalaysiaUniversity Malaya Medical Centre
Mar 15, 2022
Breast Cancer Trial in Boston (Talazoparib, Sacituzumab Govitecan)
Recruiting
- Breast Cancer
- Talazoparib
- Sacituzumab Govitecan
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Oct 25, 2021
Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,
Active, not recruiting
- Advanced Malignant Neoplasm
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 21, 2022
Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)
Recruiting
- Recurrent Glioma
- +4 more
- Talazoparib
-
Hong Kong, Hong KongDepartment of Clinical Oncology
Aug 19, 2021
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Brunswick,
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Carboplatin
- +2 more
-
New Brunswick, New Jersey
- +2 more
Jun 28, 2022
Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer
Recruiting
- Adrenal Gland Pheochromocytoma
- +3 more
- Computed Tomography
- +2 more
-
Bethesda, Maryland
- +1 more
Aug 16, 2022
Tumors, Breast Tumors Trial in Japan (talazoparib)
Active, not recruiting
- Neoplasms
- Breast Neoplasms
- talazoparib
-
Nagoya, Aichi, Japan
- +7 more
Dec 20, 2021
TNBC - Triple-Negative Breast Cancer Trial in United States (Gedatolisib, Talazoparib)
Recruiting
- TNBC - Triple-Negative Breast Cancer
- Gedatolisib
- Talazoparib
-
Chicago, Illinois
- +4 more
Jan 18, 2022
Advanced Refractory Solid Tumors, Advanced Triple Negative Breast Cancers, Metastatic Triple Negative Breast Cancers Trial in
Recruiting
- Advanced Refractory Solid Tumors
- +2 more
- Talazoparib
- Selinexor
-
Singapore, SingaporeNational University Hospital
Aug 31, 2021
Metastatic Breast Cancer, Triple Negative Breast Cancer, Hormone Receptor Positive Tumor Trial in Indianapolis, Winston-Salem
Recruiting
- Metastatic Breast Cancer
- +2 more
- Talazoparib
- ASTX727
-
Indianapolis, Indiana
- +1 more
Sep 28, 2021
Metastatic Renal Cell Carcinoma, Fumarate Hydratase Deficient Renal Cell Carcinoma, Succinate Dehydrogenase Deficient Renal Cell
Recruiting
- Metastatic Renal Cell Carcinoma
- +2 more
- Talazoparib
- Avelumab
-
Basking Ridge, New Jersey
- +6 more
Dec 21, 2021
Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022